nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—coronary artery disease—atherosclerosis	0.208	0.545	CtDrD
Losartan—type 2 diabetes mellitus—atherosclerosis	0.173	0.455	CtDrD
Losartan—AGTR1—atherosclerosis	0.11	0.551	CbGaD
Losartan—ACE—atherosclerosis	0.0637	0.318	CbGaD
Losartan—ALB—atherosclerosis	0.0261	0.13	CbGaD
Losartan—UGT1A3—Ezetimibe—atherosclerosis	0.0219	0.0736	CbGbCtD
Losartan—UGT1A3—Simvastatin—atherosclerosis	0.0203	0.0685	CbGbCtD
Losartan—UGT1A3—Lovastatin—atherosclerosis	0.0199	0.067	CbGbCtD
Losartan—SLCO1B3—Rosuvastatin—atherosclerosis	0.0162	0.0547	CbGbCtD
Losartan—UGT2B7—Ezetimibe—atherosclerosis	0.0158	0.0532	CbGbCtD
Losartan—SLCO1B3—Pravastatin—atherosclerosis	0.0148	0.0498	CbGbCtD
Losartan—UGT2B7—Simvastatin—atherosclerosis	0.0147	0.0495	CbGbCtD
Losartan—UGT2B7—Lovastatin—atherosclerosis	0.0144	0.0484	CbGbCtD
Losartan—UGT1A1—Ezetimibe—atherosclerosis	0.0137	0.046	CbGbCtD
Losartan—UGT1A1—Simvastatin—atherosclerosis	0.0127	0.0428	CbGbCtD
Losartan—UGT1A1—Lovastatin—atherosclerosis	0.0124	0.0419	CbGbCtD
Losartan—SLCO1B1—Ezetimibe—atherosclerosis	0.00946	0.0319	CbGbCtD
Losartan—SLCO1B1—Rosuvastatin—atherosclerosis	0.00946	0.0319	CbGbCtD
Losartan—SLCO1B1—Simvastatin—atherosclerosis	0.0088	0.0296	CbGbCtD
Losartan—SLCO1B1—Lovastatin—atherosclerosis	0.00861	0.029	CbGbCtD
Losartan—SLCO1B1—Pravastatin—atherosclerosis	0.00861	0.029	CbGbCtD
Losartan—SLC22A6—Pravastatin—atherosclerosis	0.00553	0.0186	CbGbCtD
Losartan—ALB—Rosuvastatin—atherosclerosis	0.00518	0.0174	CbGbCtD
Losartan—CYP3A5—Rosuvastatin—atherosclerosis	0.00416	0.014	CbGbCtD
Losartan—CYP3A5—Simvastatin—atherosclerosis	0.00387	0.013	CbGbCtD
Losartan—CYP3A5—Lovastatin—atherosclerosis	0.00379	0.0128	CbGbCtD
Losartan—CYP3A5—Pravastatin—atherosclerosis	0.00379	0.0128	CbGbCtD
Losartan—CYP2C8—Simvastatin—atherosclerosis	0.00372	0.0125	CbGbCtD
Losartan—CYP2C8—Pravastatin—atherosclerosis	0.00364	0.0123	CbGbCtD
Losartan—CYP2C8—Lovastatin—atherosclerosis	0.00364	0.0123	CbGbCtD
Losartan—CYP2C19—Rosuvastatin—atherosclerosis	0.00336	0.0113	CbGbCtD
Losartan—ACE—thoracic aorta—atherosclerosis	0.00328	0.143	CbGeAlD
Losartan—CYP2C19—Simvastatin—atherosclerosis	0.00312	0.0105	CbGbCtD
Losartan—CYP2C19—Lovastatin—atherosclerosis	0.00306	0.0103	CbGbCtD
Losartan—CYP2C9—Rosuvastatin—atherosclerosis	0.00279	0.0094	CbGbCtD
Losartan—ABCB1—Ezetimibe—atherosclerosis	0.00271	0.00913	CbGbCtD
Losartan—ACE—renal artery—atherosclerosis	0.00266	0.116	CbGeAlD
Losartan—CYP2C9—Simvastatin—atherosclerosis	0.0026	0.00874	CbGbCtD
Losartan—CYP2C9—Pravastatin—atherosclerosis	0.00254	0.00856	CbGbCtD
Losartan—CYP2C9—Lovastatin—atherosclerosis	0.00254	0.00856	CbGbCtD
Losartan—ABCB1—Simvastatin—atherosclerosis	0.00252	0.00848	CbGbCtD
Losartan—ABCB1—Pravastatin—atherosclerosis	0.00247	0.0083	CbGbCtD
Losartan—ABCB1—Lovastatin—atherosclerosis	0.00247	0.0083	CbGbCtD
Losartan—ACE—arteriole—atherosclerosis	0.00214	0.0935	CbGeAlD
Losartan—CYP3A4—Ezetimibe—atherosclerosis	0.00162	0.00547	CbGbCtD
Losartan—CYP3A4—Rosuvastatin—atherosclerosis	0.00162	0.00547	CbGbCtD
Losartan—ACE—tunica intima—atherosclerosis	0.00152	0.0663	CbGeAlD
Losartan—CYP3A4—Simvastatin—atherosclerosis	0.00151	0.00508	CbGbCtD
Losartan—CYP3A4—Lovastatin—atherosclerosis	0.00148	0.00497	CbGbCtD
Losartan—CYP3A4—Pravastatin—atherosclerosis	0.00148	0.00497	CbGbCtD
Losartan—ACE—vein—atherosclerosis	0.00127	0.0557	CbGeAlD
Losartan—ACE—umbilical vein—atherosclerosis	0.000925	0.0405	CbGeAlD
Losartan—UGT2B17—liver—atherosclerosis	0.000891	0.0389	CbGeAlD
Losartan—ACE—hindlimb—atherosclerosis	0.000847	0.037	CbGeAlD
Losartan—SLC2A9—connective tissue—atherosclerosis	0.000733	0.032	CbGeAlD
Losartan—ACE—appendage—atherosclerosis	0.000727	0.0318	CbGeAlD
Losartan—AGTR1—artery—atherosclerosis	0.000703	0.0307	CbGeAlD
Losartan—AGTR1—endothelium—atherosclerosis	0.000594	0.026	CbGeAlD
Losartan—AGTR1—blood vessel—atherosclerosis	0.000548	0.024	CbGeAlD
Losartan—ACE—artery—atherosclerosis	0.000519	0.0227	CbGeAlD
Losartan—UGT1A10—liver—atherosclerosis	0.000503	0.022	CbGeAlD
Losartan—Eprosartan—AGTR1—atherosclerosis	0.000474	0.179	CrCbGaD
Losartan—ACE—endothelium—atherosclerosis	0.000439	0.0192	CbGeAlD
Losartan—ACE—blood vessel—atherosclerosis	0.000404	0.0177	CbGeAlD
Losartan—SLC2A9—liver—atherosclerosis	0.000394	0.0172	CbGeAlD
Losartan—Azilsartan medoxomil—AGTR1—atherosclerosis	0.000386	0.146	CrCbGaD
Losartan—Forasartan—AGTR1—atherosclerosis	0.000359	0.136	CrCbGaD
Losartan—UGT1A3—liver—atherosclerosis	0.000355	0.0155	CbGeAlD
Losartan—AGTR1—connective tissue—atherosclerosis	0.000281	0.0123	CbGeAlD
Losartan—SLCO1B3—liver—atherosclerosis	0.000249	0.0109	CbGeAlD
Losartan—AGTR1—cardiovascular system—atherosclerosis	0.000244	0.0107	CbGeAlD
Losartan—Tasosartan—AGTR1—atherosclerosis	0.000218	0.0823	CrCbGaD
Losartan—AGTR1—adipose tissue—atherosclerosis	0.000215	0.00942	CbGeAlD
Losartan—Irbesartan—EDNRA—atherosclerosis	0.000214	0.0811	CrCbGaD
Losartan—ACE—connective tissue—atherosclerosis	0.000207	0.00907	CbGeAlD
Losartan—UGT2B7—liver—atherosclerosis	0.000204	0.00891	CbGeAlD
Losartan—Valsartan—AGTR1—atherosclerosis	0.000189	0.0714	CrCbGaD
Losartan—Olmesartan—AGTR1—atherosclerosis	0.000184	0.0696	CrCbGaD
Losartan—ACE—cardiovascular system—atherosclerosis	0.00018	0.00789	CbGeAlD
Losartan—Telmisartan—AGTR1—atherosclerosis	0.000177	0.0671	CrCbGaD
Losartan—UGT1A1—liver—atherosclerosis	0.000173	0.00757	CbGeAlD
Losartan—ACE—adipose tissue—atherosclerosis	0.000159	0.00696	CbGeAlD
Losartan—AGTR1—liver—atherosclerosis	0.000151	0.00661	CbGeAlD
Losartan—SLCO1B1—liver—atherosclerosis	0.000144	0.0063	CbGeAlD
Losartan—Candesartan—AGTR1—atherosclerosis	0.000143	0.0541	CrCbGaD
Losartan—Irbesartan—AGTR1—atherosclerosis	0.000143	0.0541	CrCbGaD
Losartan—ABCB1—blood vessel—atherosclerosis	0.000142	0.00623	CbGeAlD
Losartan—CYP2C9—cardiovascular system—atherosclerosis	0.000118	0.00515	CbGeAlD
Losartan—ALB—liver—atherosclerosis	0.000117	0.0051	CbGeAlD
Losartan—Ill-defined disorder—Lovastatin—atherosclerosis	0.000112	0.00193	CcSEcCtD
Losartan—Telmisartan—PPARG—atherosclerosis	0.000112	0.0422	CrCbGaD
Losartan—ACE—liver—atherosclerosis	0.000112	0.00488	CbGeAlD
Losartan—Flatulence—Simvastatin—atherosclerosis	0.000111	0.00192	CcSEcCtD
Losartan—Tinnitus—Niacin—atherosclerosis	0.000111	0.00192	CcSEcCtD
Losartan—Erythema multiforme—Pravastatin—atherosclerosis	0.000111	0.00191	CcSEcCtD
Losartan—Dysgeusia—Simvastatin—atherosclerosis	0.000111	0.00191	CcSEcCtD
Losartan—Flushing—Niacin—atherosclerosis	0.000111	0.00191	CcSEcCtD
Losartan—Angioedema—Lovastatin—atherosclerosis	0.00011	0.0019	CcSEcCtD
Losartan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00011	0.0019	CcSEcCtD
Losartan—Anaemia—Ezetimibe—atherosclerosis	0.000109	0.00189	CcSEcCtD
Losartan—Tinnitus—Pravastatin—atherosclerosis	0.000109	0.00189	CcSEcCtD
Losartan—Malaise—Lovastatin—atherosclerosis	0.000109	0.00188	CcSEcCtD
Losartan—Flushing—Pravastatin—atherosclerosis	0.000109	0.00188	CcSEcCtD
Losartan—Muscle spasms—Simvastatin—atherosclerosis	0.000109	0.00187	CcSEcCtD
Losartan—Vertigo—Lovastatin—atherosclerosis	0.000108	0.00187	CcSEcCtD
Losartan—Angioedema—Ezetimibe—atherosclerosis	0.000108	0.00187	CcSEcCtD
Losartan—Angiopathy—Niacin—atherosclerosis	0.000108	0.00187	CcSEcCtD
Losartan—Leukopenia—Lovastatin—atherosclerosis	0.000108	0.00187	CcSEcCtD
Losartan—Malaise—Ezetimibe—atherosclerosis	0.000107	0.00184	CcSEcCtD
Losartan—Vision blurred—Simvastatin—atherosclerosis	0.000106	0.00184	CcSEcCtD
Losartan—Arrhythmia—Niacin—atherosclerosis	0.000106	0.00184	CcSEcCtD
Losartan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000106	0.00183	CcSEcCtD
Losartan—Tremor—Simvastatin—atherosclerosis	0.000106	0.00183	CcSEcCtD
Losartan—CYP3A5—adipose tissue—atherosclerosis	0.000105	0.00461	CbGeAlD
Losartan—Alopecia—Niacin—atherosclerosis	0.000105	0.00182	CcSEcCtD
Losartan—Insomnia—Rosuvastatin—atherosclerosis	0.000105	0.00182	CcSEcCtD
Losartan—Ill-defined disorder—Simvastatin—atherosclerosis	0.000105	0.00181	CcSEcCtD
Losartan—Arrhythmia—Pravastatin—atherosclerosis	0.000105	0.00181	CcSEcCtD
Losartan—Palpitations—Ezetimibe—atherosclerosis	0.000105	0.00181	CcSEcCtD
Losartan—Paraesthesia—Rosuvastatin—atherosclerosis	0.000104	0.0018	CcSEcCtD
Losartan—Anaemia—Simvastatin—atherosclerosis	0.000104	0.0018	CcSEcCtD
Losartan—Erythema—Niacin—atherosclerosis	0.000104	0.00179	CcSEcCtD
Losartan—Alopecia—Pravastatin—atherosclerosis	0.000104	0.00179	CcSEcCtD
Losartan—Cough—Ezetimibe—atherosclerosis	0.000103	0.00178	CcSEcCtD
Losartan—Angioedema—Simvastatin—atherosclerosis	0.000103	0.00178	CcSEcCtD
Losartan—Myalgia—Lovastatin—atherosclerosis	0.000103	0.00177	CcSEcCtD
Losartan—Chest pain—Lovastatin—atherosclerosis	0.000103	0.00177	CcSEcCtD
Losartan—Arthralgia—Lovastatin—atherosclerosis	0.000103	0.00177	CcSEcCtD
Losartan—Anxiety—Lovastatin—atherosclerosis	0.000102	0.00177	CcSEcCtD
Losartan—Dyspepsia—Rosuvastatin—atherosclerosis	0.000102	0.00177	CcSEcCtD
Losartan—Flatulence—Niacin—atherosclerosis	0.000102	0.00176	CcSEcCtD
Losartan—Malaise—Simvastatin—atherosclerosis	0.000102	0.00176	CcSEcCtD
Losartan—Tension—Niacin—atherosclerosis	0.000102	0.00176	CcSEcCtD
Losartan—Discomfort—Lovastatin—atherosclerosis	0.000102	0.00175	CcSEcCtD
Losartan—Vertigo—Simvastatin—atherosclerosis	0.000101	0.00175	CcSEcCtD
Losartan—Leukopenia—Simvastatin—atherosclerosis	0.000101	0.00174	CcSEcCtD
Losartan—Chest pain—Ezetimibe—atherosclerosis	0.000101	0.00174	CcSEcCtD
Losartan—Myalgia—Ezetimibe—atherosclerosis	0.000101	0.00174	CcSEcCtD
Losartan—Arthralgia—Ezetimibe—atherosclerosis	0.000101	0.00174	CcSEcCtD
Losartan—Nervousness—Niacin—atherosclerosis	0.000101	0.00174	CcSEcCtD
Losartan—Flatulence—Pravastatin—atherosclerosis	0.000101	0.00174	CcSEcCtD
Losartan—Dry mouth—Lovastatin—atherosclerosis	0.0001	0.00174	CcSEcCtD
Losartan—Tension—Pravastatin—atherosclerosis	0.0001	0.00173	CcSEcCtD
Losartan—Dysgeusia—Pravastatin—atherosclerosis	9.99e-05	0.00173	CcSEcCtD
Losartan—Muscle spasms—Niacin—atherosclerosis	9.97e-05	0.00172	CcSEcCtD
Losartan—Discomfort—Ezetimibe—atherosclerosis	9.96e-05	0.00172	CcSEcCtD
Losartan—Pain—Rosuvastatin—atherosclerosis	9.94e-05	0.00172	CcSEcCtD
Losartan—Constipation—Rosuvastatin—atherosclerosis	9.94e-05	0.00172	CcSEcCtD
Losartan—Confusional state—Lovastatin—atherosclerosis	9.93e-05	0.00171	CcSEcCtD
Losartan—Nervousness—Pravastatin—atherosclerosis	9.91e-05	0.00171	CcSEcCtD
Losartan—Dry mouth—Ezetimibe—atherosclerosis	9.86e-05	0.0017	CcSEcCtD
Losartan—Anaphylactic shock—Lovastatin—atherosclerosis	9.85e-05	0.0017	CcSEcCtD
Losartan—Muscle spasms—Pravastatin—atherosclerosis	9.81e-05	0.00169	CcSEcCtD
Losartan—Infection—Lovastatin—atherosclerosis	9.79e-05	0.00169	CcSEcCtD
Losartan—Vision blurred—Niacin—atherosclerosis	9.77e-05	0.00169	CcSEcCtD
Losartan—Confusional state—Ezetimibe—atherosclerosis	9.74e-05	0.00168	CcSEcCtD
Losartan—Anaphylactic shock—Ezetimibe—atherosclerosis	9.66e-05	0.00167	CcSEcCtD
Losartan—Thrombocytopenia—Lovastatin—atherosclerosis	9.64e-05	0.00167	CcSEcCtD
Losartan—Vision blurred—Pravastatin—atherosclerosis	9.62e-05	0.00166	CcSEcCtD
Losartan—Myalgia—Simvastatin—atherosclerosis	9.61e-05	0.00166	CcSEcCtD
Losartan—Chest pain—Simvastatin—atherosclerosis	9.61e-05	0.00166	CcSEcCtD
Losartan—Arthralgia—Simvastatin—atherosclerosis	9.61e-05	0.00166	CcSEcCtD
Losartan—Infection—Ezetimibe—atherosclerosis	9.6e-05	0.00166	CcSEcCtD
Losartan—Feeling abnormal—Rosuvastatin—atherosclerosis	9.58e-05	0.00165	CcSEcCtD
Losartan—Anxiety—Simvastatin—atherosclerosis	9.58e-05	0.00165	CcSEcCtD
Losartan—Tremor—Pravastatin—atherosclerosis	9.56e-05	0.00165	CcSEcCtD
Losartan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	9.5e-05	0.00164	CcSEcCtD
Losartan—Discomfort—Simvastatin—atherosclerosis	9.5e-05	0.00164	CcSEcCtD
Losartan—Nervous system disorder—Ezetimibe—atherosclerosis	9.47e-05	0.00164	CcSEcCtD
Losartan—Angioedema—Niacin—atherosclerosis	9.47e-05	0.00164	CcSEcCtD
Losartan—Ill-defined disorder—Pravastatin—atherosclerosis	9.47e-05	0.00164	CcSEcCtD
Losartan—Thrombocytopenia—Ezetimibe—atherosclerosis	9.46e-05	0.00163	CcSEcCtD
Losartan—Anaemia—Pravastatin—atherosclerosis	9.43e-05	0.00163	CcSEcCtD
Losartan—Anorexia—Lovastatin—atherosclerosis	9.39e-05	0.00162	CcSEcCtD
Losartan—CYP2C19—liver—atherosclerosis	9.39e-05	0.0041	CbGeAlD
Losartan—Angioedema—Pravastatin—atherosclerosis	9.33e-05	0.00161	CcSEcCtD
Losartan—Vertigo—Niacin—atherosclerosis	9.31e-05	0.00161	CcSEcCtD
Losartan—Syncope—Niacin—atherosclerosis	9.3e-05	0.00161	CcSEcCtD
Losartan—Confusional state—Simvastatin—atherosclerosis	9.29e-05	0.0016	CcSEcCtD
Losartan—Leukopenia—Niacin—atherosclerosis	9.28e-05	0.0016	CcSEcCtD
Losartan—Urticaria—Rosuvastatin—atherosclerosis	9.23e-05	0.00159	CcSEcCtD
Losartan—Anaphylactic shock—Simvastatin—atherosclerosis	9.21e-05	0.00159	CcSEcCtD
Losartan—Oedema—Simvastatin—atherosclerosis	9.21e-05	0.00159	CcSEcCtD
Losartan—Malaise—Pravastatin—atherosclerosis	9.2e-05	0.00159	CcSEcCtD
Losartan—Abdominal pain—Rosuvastatin—atherosclerosis	9.19e-05	0.00159	CcSEcCtD
Losartan—Vertigo—Pravastatin—atherosclerosis	9.17e-05	0.00158	CcSEcCtD
Losartan—Palpitations—Niacin—atherosclerosis	9.16e-05	0.00158	CcSEcCtD
Losartan—Infection—Simvastatin—atherosclerosis	9.15e-05	0.00158	CcSEcCtD
Losartan—Leukopenia—Pravastatin—atherosclerosis	9.14e-05	0.00158	CcSEcCtD
Losartan—Loss of consciousness—Niacin—atherosclerosis	9.11e-05	0.00157	CcSEcCtD
Losartan—Cough—Niacin—atherosclerosis	9.05e-05	0.00156	CcSEcCtD
Losartan—Thrombocytopenia—Simvastatin—atherosclerosis	9.02e-05	0.00156	CcSEcCtD
Losartan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	8.97e-05	0.00155	CcSEcCtD
Losartan—Insomnia—Lovastatin—atherosclerosis	8.91e-05	0.00154	CcSEcCtD
Losartan—Cough—Pravastatin—atherosclerosis	8.91e-05	0.00154	CcSEcCtD
Losartan—Paraesthesia—Lovastatin—atherosclerosis	8.84e-05	0.00153	CcSEcCtD
Losartan—Myalgia—Niacin—atherosclerosis	8.83e-05	0.00152	CcSEcCtD
Losartan—Arthralgia—Niacin—atherosclerosis	8.83e-05	0.00152	CcSEcCtD
Losartan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	8.8e-05	0.00152	CcSEcCtD
Losartan—Anorexia—Simvastatin—atherosclerosis	8.78e-05	0.00152	CcSEcCtD
Losartan—Dyspnoea—Lovastatin—atherosclerosis	8.78e-05	0.00152	CcSEcCtD
Losartan—Insomnia—Ezetimibe—atherosclerosis	8.74e-05	0.00151	CcSEcCtD
Losartan—Chest pain—Pravastatin—atherosclerosis	8.69e-05	0.0015	CcSEcCtD
Losartan—Myalgia—Pravastatin—atherosclerosis	8.69e-05	0.0015	CcSEcCtD
Losartan—Arthralgia—Pravastatin—atherosclerosis	8.69e-05	0.0015	CcSEcCtD
Losartan—Paraesthesia—Ezetimibe—atherosclerosis	8.68e-05	0.0015	CcSEcCtD
Losartan—Dyspepsia—Lovastatin—atherosclerosis	8.67e-05	0.0015	CcSEcCtD
Losartan—Anxiety—Pravastatin—atherosclerosis	8.66e-05	0.0015	CcSEcCtD
Losartan—Dry mouth—Niacin—atherosclerosis	8.63e-05	0.00149	CcSEcCtD
Losartan—Dyspnoea—Ezetimibe—atherosclerosis	8.61e-05	0.00149	CcSEcCtD
Losartan—Discomfort—Pravastatin—atherosclerosis	8.59e-05	0.00148	CcSEcCtD
Losartan—Hypersensitivity—Rosuvastatin—atherosclerosis	8.56e-05	0.00148	CcSEcCtD
Losartan—Decreased appetite—Lovastatin—atherosclerosis	8.56e-05	0.00148	CcSEcCtD
Losartan—Dyspepsia—Ezetimibe—atherosclerosis	8.5e-05	0.00147	CcSEcCtD
Losartan—Fatigue—Lovastatin—atherosclerosis	8.49e-05	0.00147	CcSEcCtD
Losartan—Anaphylactic shock—Niacin—atherosclerosis	8.46e-05	0.00146	CcSEcCtD
Losartan—Oedema—Niacin—atherosclerosis	8.46e-05	0.00146	CcSEcCtD
Losartan—Pain—Lovastatin—atherosclerosis	8.42e-05	0.00145	CcSEcCtD
Losartan—Constipation—Lovastatin—atherosclerosis	8.42e-05	0.00145	CcSEcCtD
Losartan—Confusional state—Pravastatin—atherosclerosis	8.4e-05	0.00145	CcSEcCtD
Losartan—Decreased appetite—Ezetimibe—atherosclerosis	8.4e-05	0.00145	CcSEcCtD
Losartan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	8.39e-05	0.00145	CcSEcCtD
Losartan—Asthenia—Rosuvastatin—atherosclerosis	8.34e-05	0.00144	CcSEcCtD
Losartan—Insomnia—Simvastatin—atherosclerosis	8.33e-05	0.00144	CcSEcCtD
Losartan—Oedema—Pravastatin—atherosclerosis	8.33e-05	0.00144	CcSEcCtD
Losartan—Anaphylactic shock—Pravastatin—atherosclerosis	8.33e-05	0.00144	CcSEcCtD
Losartan—Fatigue—Ezetimibe—atherosclerosis	8.33e-05	0.00144	CcSEcCtD
Losartan—Shock—Niacin—atherosclerosis	8.32e-05	0.00144	CcSEcCtD
Losartan—Infection—Pravastatin—atherosclerosis	8.28e-05	0.00143	CcSEcCtD
Losartan—Paraesthesia—Simvastatin—atherosclerosis	8.27e-05	0.00143	CcSEcCtD
Losartan—Constipation—Ezetimibe—atherosclerosis	8.26e-05	0.00143	CcSEcCtD
Losartan—Pain—Ezetimibe—atherosclerosis	8.26e-05	0.00143	CcSEcCtD
Losartan—Tachycardia—Niacin—atherosclerosis	8.26e-05	0.00143	CcSEcCtD
Losartan—Pruritus—Rosuvastatin—atherosclerosis	8.22e-05	0.00142	CcSEcCtD
Losartan—Dyspnoea—Simvastatin—atherosclerosis	8.21e-05	0.00142	CcSEcCtD
Losartan—CYP2C8—liver—atherosclerosis	8.19e-05	0.00358	CbGeAlD
Losartan—Hyperhidrosis—Niacin—atherosclerosis	8.18e-05	0.00141	CcSEcCtD
Losartan—Thrombocytopenia—Pravastatin—atherosclerosis	8.16e-05	0.00141	CcSEcCtD
Losartan—Feeling abnormal—Lovastatin—atherosclerosis	8.12e-05	0.0014	CcSEcCtD
Losartan—Dyspepsia—Simvastatin—atherosclerosis	8.11e-05	0.0014	CcSEcCtD
Losartan—Anorexia—Niacin—atherosclerosis	8.06e-05	0.00139	CcSEcCtD
Losartan—Gastrointestinal pain—Lovastatin—atherosclerosis	8.05e-05	0.00139	CcSEcCtD
Losartan—Hyperhidrosis—Pravastatin—atherosclerosis	8.05e-05	0.00139	CcSEcCtD
Losartan—Decreased appetite—Simvastatin—atherosclerosis	8.01e-05	0.00138	CcSEcCtD
Losartan—Feeling abnormal—Ezetimibe—atherosclerosis	7.96e-05	0.00137	CcSEcCtD
Losartan—Diarrhoea—Rosuvastatin—atherosclerosis	7.95e-05	0.00137	CcSEcCtD
Losartan—Fatigue—Simvastatin—atherosclerosis	7.94e-05	0.00137	CcSEcCtD
Losartan—Anorexia—Pravastatin—atherosclerosis	7.94e-05	0.00137	CcSEcCtD
Losartan—Hypotension—Niacin—atherosclerosis	7.91e-05	0.00136	CcSEcCtD
Losartan—Gastrointestinal pain—Ezetimibe—atherosclerosis	7.9e-05	0.00136	CcSEcCtD
Losartan—Pain—Simvastatin—atherosclerosis	7.88e-05	0.00136	CcSEcCtD
Losartan—Constipation—Simvastatin—atherosclerosis	7.88e-05	0.00136	CcSEcCtD
Losartan—Urticaria—Lovastatin—atherosclerosis	7.83e-05	0.00135	CcSEcCtD
Losartan—Body temperature increased—Lovastatin—atherosclerosis	7.79e-05	0.00134	CcSEcCtD
Losartan—Abdominal pain—Lovastatin—atherosclerosis	7.79e-05	0.00134	CcSEcCtD
Losartan—Musculoskeletal discomfort—Niacin—atherosclerosis	7.71e-05	0.00133	CcSEcCtD
Losartan—Dizziness—Rosuvastatin—atherosclerosis	7.69e-05	0.00133	CcSEcCtD
Losartan—Urticaria—Ezetimibe—atherosclerosis	7.68e-05	0.00133	CcSEcCtD
Losartan—CYP1A2—liver—atherosclerosis	7.67e-05	0.00335	CbGeAlD
Losartan—Insomnia—Niacin—atherosclerosis	7.65e-05	0.00132	CcSEcCtD
Losartan—Abdominal pain—Ezetimibe—atherosclerosis	7.64e-05	0.00132	CcSEcCtD
Losartan—Body temperature increased—Ezetimibe—atherosclerosis	7.64e-05	0.00132	CcSEcCtD
Losartan—Paraesthesia—Niacin—atherosclerosis	7.6e-05	0.00131	CcSEcCtD
Losartan—Feeling abnormal—Simvastatin—atherosclerosis	7.59e-05	0.00131	CcSEcCtD
Losartan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	7.59e-05	0.00131	CcSEcCtD
Losartan—Dyspnoea—Niacin—atherosclerosis	7.54e-05	0.0013	CcSEcCtD
Losartan—Gastrointestinal pain—Simvastatin—atherosclerosis	7.53e-05	0.0013	CcSEcCtD
Losartan—Insomnia—Pravastatin—atherosclerosis	7.53e-05	0.0013	CcSEcCtD
Losartan—Somnolence—Niacin—atherosclerosis	7.52e-05	0.0013	CcSEcCtD
Losartan—Paraesthesia—Pravastatin—atherosclerosis	7.48e-05	0.00129	CcSEcCtD
Losartan—Dyspepsia—Niacin—atherosclerosis	7.45e-05	0.00129	CcSEcCtD
Losartan—Dyspnoea—Pravastatin—atherosclerosis	7.43e-05	0.00128	CcSEcCtD
Losartan—CYP3A5—liver—atherosclerosis	7.39e-05	0.00323	CbGeAlD
Losartan—Decreased appetite—Niacin—atherosclerosis	7.35e-05	0.00127	CcSEcCtD
Losartan—Dyspepsia—Pravastatin—atherosclerosis	7.33e-05	0.00127	CcSEcCtD
Losartan—Rash—Rosuvastatin—atherosclerosis	7.33e-05	0.00127	CcSEcCtD
Losartan—Dermatitis—Rosuvastatin—atherosclerosis	7.32e-05	0.00126	CcSEcCtD
Losartan—Urticaria—Simvastatin—atherosclerosis	7.32e-05	0.00126	CcSEcCtD
Losartan—Body temperature increased—Simvastatin—atherosclerosis	7.28e-05	0.00126	CcSEcCtD
Losartan—Abdominal pain—Simvastatin—atherosclerosis	7.28e-05	0.00126	CcSEcCtD
Losartan—Headache—Rosuvastatin—atherosclerosis	7.28e-05	0.00126	CcSEcCtD
Losartan—CYP2C9—liver—atherosclerosis	7.28e-05	0.00318	CbGeAlD
Losartan—Hypersensitivity—Lovastatin—atherosclerosis	7.26e-05	0.00125	CcSEcCtD
Losartan—Decreased appetite—Pravastatin—atherosclerosis	7.24e-05	0.00125	CcSEcCtD
Losartan—Pain—Niacin—atherosclerosis	7.23e-05	0.00125	CcSEcCtD
Losartan—Fatigue—Pravastatin—atherosclerosis	7.18e-05	0.00124	CcSEcCtD
Losartan—Pain—Pravastatin—atherosclerosis	7.12e-05	0.00123	CcSEcCtD
Losartan—Constipation—Pravastatin—atherosclerosis	7.12e-05	0.00123	CcSEcCtD
Losartan—Hypersensitivity—Ezetimibe—atherosclerosis	7.12e-05	0.00123	CcSEcCtD
Losartan—Asthenia—Lovastatin—atherosclerosis	7.07e-05	0.00122	CcSEcCtD
Losartan—Pruritus—Lovastatin—atherosclerosis	6.97e-05	0.0012	CcSEcCtD
Losartan—Asthenia—Ezetimibe—atherosclerosis	6.93e-05	0.0012	CcSEcCtD
Losartan—Gastrointestinal pain—Niacin—atherosclerosis	6.92e-05	0.00119	CcSEcCtD
Losartan—Nausea—Rosuvastatin—atherosclerosis	6.9e-05	0.00119	CcSEcCtD
Losartan—Feeling abnormal—Pravastatin—atherosclerosis	6.86e-05	0.00119	CcSEcCtD
Losartan—Pruritus—Ezetimibe—atherosclerosis	6.84e-05	0.00118	CcSEcCtD
Losartan—Gastrointestinal pain—Pravastatin—atherosclerosis	6.81e-05	0.00118	CcSEcCtD
Losartan—Hypersensitivity—Simvastatin—atherosclerosis	6.79e-05	0.00117	CcSEcCtD
Losartan—Diarrhoea—Lovastatin—atherosclerosis	6.74e-05	0.00116	CcSEcCtD
Losartan—Urticaria—Niacin—atherosclerosis	6.72e-05	0.00116	CcSEcCtD
Losartan—Body temperature increased—Niacin—atherosclerosis	6.69e-05	0.00115	CcSEcCtD
Losartan—Abdominal pain—Niacin—atherosclerosis	6.69e-05	0.00115	CcSEcCtD
Losartan—Urticaria—Pravastatin—atherosclerosis	6.62e-05	0.00114	CcSEcCtD
Losartan—Asthenia—Simvastatin—atherosclerosis	6.61e-05	0.00114	CcSEcCtD
Losartan—Diarrhoea—Ezetimibe—atherosclerosis	6.61e-05	0.00114	CcSEcCtD
Losartan—Abdominal pain—Pravastatin—atherosclerosis	6.58e-05	0.00114	CcSEcCtD
Losartan—Body temperature increased—Pravastatin—atherosclerosis	6.58e-05	0.00114	CcSEcCtD
Losartan—Pruritus—Simvastatin—atherosclerosis	6.52e-05	0.00113	CcSEcCtD
Losartan—Dizziness—Lovastatin—atherosclerosis	6.51e-05	0.00112	CcSEcCtD
Losartan—Dizziness—Ezetimibe—atherosclerosis	6.39e-05	0.0011	CcSEcCtD
Losartan—ABCB1—cardiovascular system—atherosclerosis	6.35e-05	0.00278	CbGeAlD
Losartan—Diarrhoea—Simvastatin—atherosclerosis	6.3e-05	0.00109	CcSEcCtD
Losartan—Vomiting—Lovastatin—atherosclerosis	6.26e-05	0.00108	CcSEcCtD
Losartan—Hypersensitivity—Niacin—atherosclerosis	6.23e-05	0.00108	CcSEcCtD
Losartan—Rash—Lovastatin—atherosclerosis	6.21e-05	0.00107	CcSEcCtD
Losartan—Dermatitis—Lovastatin—atherosclerosis	6.2e-05	0.00107	CcSEcCtD
Losartan—Headache—Lovastatin—atherosclerosis	6.17e-05	0.00107	CcSEcCtD
Losartan—Vomiting—Ezetimibe—atherosclerosis	6.14e-05	0.00106	CcSEcCtD
Losartan—Hypersensitivity—Pravastatin—atherosclerosis	6.14e-05	0.00106	CcSEcCtD
Losartan—Dizziness—Simvastatin—atherosclerosis	6.09e-05	0.00105	CcSEcCtD
Losartan—Rash—Ezetimibe—atherosclerosis	6.09e-05	0.00105	CcSEcCtD
Losartan—Dermatitis—Ezetimibe—atherosclerosis	6.09e-05	0.00105	CcSEcCtD
Losartan—Asthenia—Niacin—atherosclerosis	6.07e-05	0.00105	CcSEcCtD
Losartan—Headache—Ezetimibe—atherosclerosis	6.05e-05	0.00105	CcSEcCtD
Losartan—Pruritus—Niacin—atherosclerosis	5.99e-05	0.00103	CcSEcCtD
Losartan—Asthenia—Pravastatin—atherosclerosis	5.98e-05	0.00103	CcSEcCtD
Losartan—Pruritus—Pravastatin—atherosclerosis	5.89e-05	0.00102	CcSEcCtD
Losartan—Vomiting—Simvastatin—atherosclerosis	5.86e-05	0.00101	CcSEcCtD
Losartan—Nausea—Lovastatin—atherosclerosis	5.85e-05	0.00101	CcSEcCtD
Losartan—Rash—Simvastatin—atherosclerosis	5.81e-05	0.001	CcSEcCtD
Losartan—Dermatitis—Simvastatin—atherosclerosis	5.8e-05	0.001	CcSEcCtD
Losartan—Diarrhoea—Niacin—atherosclerosis	5.79e-05	0.000999	CcSEcCtD
Losartan—Headache—Simvastatin—atherosclerosis	5.77e-05	0.000997	CcSEcCtD
Losartan—Nausea—Ezetimibe—atherosclerosis	5.74e-05	0.000991	CcSEcCtD
Losartan—Diarrhoea—Pravastatin—atherosclerosis	5.7e-05	0.000984	CcSEcCtD
Losartan—ABCB1—adipose tissue—atherosclerosis	5.6e-05	0.00245	CbGeAlD
Losartan—Dizziness—Niacin—atherosclerosis	5.59e-05	0.000966	CcSEcCtD
Losartan—CYP3A4—liver—atherosclerosis	5.55e-05	0.00243	CbGeAlD
Losartan—Dizziness—Pravastatin—atherosclerosis	5.51e-05	0.000951	CcSEcCtD
Losartan—Nausea—Simvastatin—atherosclerosis	5.47e-05	0.000945	CcSEcCtD
Losartan—Vomiting—Niacin—atherosclerosis	5.38e-05	0.000929	CcSEcCtD
Losartan—Rash—Niacin—atherosclerosis	5.33e-05	0.000921	CcSEcCtD
Losartan—Dermatitis—Niacin—atherosclerosis	5.33e-05	0.00092	CcSEcCtD
Losartan—Headache—Niacin—atherosclerosis	5.3e-05	0.000915	CcSEcCtD
Losartan—Vomiting—Pravastatin—atherosclerosis	5.3e-05	0.000914	CcSEcCtD
Losartan—Rash—Pravastatin—atherosclerosis	5.25e-05	0.000907	CcSEcCtD
Losartan—Dermatitis—Pravastatin—atherosclerosis	5.25e-05	0.000906	CcSEcCtD
Losartan—Headache—Pravastatin—atherosclerosis	5.22e-05	0.000901	CcSEcCtD
Losartan—Nausea—Niacin—atherosclerosis	5.03e-05	0.000868	CcSEcCtD
Losartan—Nausea—Pravastatin—atherosclerosis	4.95e-05	0.000854	CcSEcCtD
Losartan—Valsartan—ALB—atherosclerosis	4.47e-05	0.0169	CrCbGaD
Losartan—ABCB1—liver—atherosclerosis	3.93e-05	0.00172	CbGeAlD
Losartan—CYP3A4—Metabolism—FABP4—atherosclerosis	2.14e-06	5.56e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LCAT—atherosclerosis	2.14e-06	5.56e-05	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	2.14e-06	5.56e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—INS—atherosclerosis	2.12e-06	5.5e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.11e-06	5.47e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SCARB1—atherosclerosis	2.11e-06	5.47e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOA4—atherosclerosis	2.1e-06	5.46e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—atherosclerosis	2.09e-06	5.43e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.09e-06	5.43e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.08e-06	5.41e-05	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—atherosclerosis	2.08e-06	5.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.08e-06	5.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LIPC—atherosclerosis	2.08e-06	5.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOC3—atherosclerosis	2.07e-06	5.36e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.07e-06	5.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	2.07e-06	5.36e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SCARB1—atherosclerosis	2.06e-06	5.34e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LDLR—atherosclerosis	2.06e-06	5.33e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	2.05e-06	5.33e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.05e-06	5.33e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—atherosclerosis	2.05e-06	5.32e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.04e-06	5.3e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.02e-06	5.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.02e-06	5.24e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.01e-06	5.22e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CETP—atherosclerosis	2.01e-06	5.21e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2e-06	5.19e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALOX5—atherosclerosis	2e-06	5.18e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.99e-06	5.17e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.99e-06	5.16e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—atherosclerosis	1.98e-06	5.14e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCA1—atherosclerosis	1.98e-06	5.13e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.97e-06	5.11e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—atherosclerosis	1.95e-06	5.06e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—atherosclerosis	1.95e-06	5.05e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—INS—atherosclerosis	1.94e-06	5.04e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMGCR—atherosclerosis	1.94e-06	5.04e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NFKB1—atherosclerosis	1.93e-06	5.01e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.92e-06	4.99e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.91e-06	4.96e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.91e-06	4.94e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK8—atherosclerosis	1.9e-06	4.92e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—atherosclerosis	1.89e-06	4.91e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOB—atherosclerosis	1.89e-06	4.89e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.87e-06	4.86e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—NOS3—atherosclerosis	1.86e-06	4.83e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.84e-06	4.78e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.84e-06	4.76e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.82e-06	4.71e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOA2—atherosclerosis	1.81e-06	4.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.81e-06	4.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.81e-06	4.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.81e-06	4.7e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—LPL—atherosclerosis	1.8e-06	4.67e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.8e-06	4.66e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.79e-06	4.64e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.79e-06	4.64e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—atherosclerosis	1.78e-06	4.62e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.78e-06	4.61e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LIPC—atherosclerosis	1.78e-06	4.61e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.78e-06	4.6e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOC3—atherosclerosis	1.77e-06	4.58e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GPX1—atherosclerosis	1.76e-06	4.56e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LDLR—atherosclerosis	1.76e-06	4.56e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—atherosclerosis	1.75e-06	4.55e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—atherosclerosis	1.74e-06	4.5e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ABCA1—atherosclerosis	1.73e-06	4.49e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—atherosclerosis	1.73e-06	4.49e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LPA—atherosclerosis	1.73e-06	4.48e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CETP—atherosclerosis	1.72e-06	4.45e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CD36—atherosclerosis	1.71e-06	4.44e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.71e-06	4.43e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—NOS3—atherosclerosis	1.71e-06	4.42e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—atherosclerosis	1.7e-06	4.41e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—HMOX1—atherosclerosis	1.7e-06	4.4e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BGN—atherosclerosis	1.67e-06	4.34e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—atherosclerosis	1.66e-06	4.3e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOA5—atherosclerosis	1.66e-06	4.3e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.64e-06	4.26e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.64e-06	4.25e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—atherosclerosis	1.64e-06	4.25e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOB—atherosclerosis	1.63e-06	4.24e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOB—atherosclerosis	1.63e-06	4.21e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.62e-06	4.21e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.62e-06	4.2e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—atherosclerosis	1.61e-06	4.17e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.6e-06	4.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.59e-06	4.14e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARA—atherosclerosis	1.59e-06	4.13e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.59e-06	4.12e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—atherosclerosis	1.59e-06	4.12e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—atherosclerosis	1.58e-06	4.1e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LPL—atherosclerosis	1.56e-06	4.05e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—atherosclerosis	1.56e-06	4.05e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.55e-06	4.02e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—LPL—atherosclerosis	1.55e-06	4.02e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AGT—atherosclerosis	1.54e-06	4e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.54e-06	3.99e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.52e-06	3.95e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GPX1—atherosclerosis	1.52e-06	3.95e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GPX1—atherosclerosis	1.51e-06	3.93e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOE—atherosclerosis	1.51e-06	3.92e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CAV1—atherosclerosis	1.5e-06	3.88e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOA1—atherosclerosis	1.49e-06	3.87e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMOX1—atherosclerosis	1.49e-06	3.86e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CD36—atherosclerosis	1.48e-06	3.85e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CD36—atherosclerosis	1.47e-06	3.82e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOB—atherosclerosis	1.46e-06	3.78e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOB—atherosclerosis	1.42e-06	3.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.42e-06	3.68e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.41e-06	3.64e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.4e-06	3.63e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—atherosclerosis	1.4e-06	3.62e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LPL—atherosclerosis	1.39e-06	3.61e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.39e-06	3.6e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—atherosclerosis	1.39e-06	3.59e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.38e-06	3.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.38e-06	3.58e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARA—atherosclerosis	1.38e-06	3.58e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LIPC—atherosclerosis	1.37e-06	3.56e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARA—atherosclerosis	1.37e-06	3.55e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOC3—atherosclerosis	1.36e-06	3.54e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.36e-06	3.53e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LPL—atherosclerosis	1.36e-06	3.53e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GPX1—atherosclerosis	1.36e-06	3.52e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LDLR—atherosclerosis	1.36e-06	3.52e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AGT—atherosclerosis	1.34e-06	3.46e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOB—atherosclerosis	1.33e-06	3.45e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AGT—atherosclerosis	1.33e-06	3.44e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GPX1—atherosclerosis	1.33e-06	3.44e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CETP—atherosclerosis	1.32e-06	3.43e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD36—atherosclerosis	1.32e-06	3.43e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—atherosclerosis	1.32e-06	3.41e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOE—atherosclerosis	1.31e-06	3.39e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOE—atherosclerosis	1.3e-06	3.37e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CAV1—atherosclerosis	1.3e-06	3.36e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.29e-06	3.36e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOA1—atherosclerosis	1.29e-06	3.35e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD36—atherosclerosis	1.29e-06	3.35e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—INS—atherosclerosis	1.29e-06	3.35e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CAV1—atherosclerosis	1.29e-06	3.34e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOA1—atherosclerosis	1.29e-06	3.33e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LPL—atherosclerosis	1.27e-06	3.29e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.27e-06	3.29e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.25e-06	3.25e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GPX1—atherosclerosis	1.24e-06	3.21e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—atherosclerosis	1.24e-06	3.21e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARA—atherosclerosis	1.23e-06	3.19e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—atherosclerosis	1.22e-06	3.17e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—atherosclerosis	1.21e-06	3.14e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD36—atherosclerosis	1.21e-06	3.13e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARA—atherosclerosis	1.2e-06	3.11e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.2e-06	3.11e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AGT—atherosclerosis	1.19e-06	3.09e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.19e-06	3.08e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—atherosclerosis	1.18e-06	3.07e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.18e-06	3.06e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—atherosclerosis	1.17e-06	3.04e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOE—atherosclerosis	1.17e-06	3.03e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—atherosclerosis	1.17e-06	3.03e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AGT—atherosclerosis	1.16e-06	3.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CAV1—atherosclerosis	1.16e-06	3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOA1—atherosclerosis	1.15e-06	2.99e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.14e-06	2.97e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOE—atherosclerosis	1.14e-06	2.96e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—atherosclerosis	1.14e-06	2.96e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOB—atherosclerosis	1.14e-06	2.95e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—atherosclerosis	1.13e-06	2.94e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NOS3—atherosclerosis	1.13e-06	2.93e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CAV1—atherosclerosis	1.13e-06	2.93e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOA1—atherosclerosis	1.13e-06	2.92e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARA—atherosclerosis	1.12e-06	2.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—atherosclerosis	1.12e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—INS—atherosclerosis	1.12e-06	2.9e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—INS—atherosclerosis	1.11e-06	2.88e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.11e-06	2.87e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—atherosclerosis	1.1e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AGT—atherosclerosis	1.09e-06	2.82e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LPL—atherosclerosis	1.09e-06	2.81e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.07e-06	2.77e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOE—atherosclerosis	1.06e-06	2.76e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GPX1—atherosclerosis	1.06e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CAV1—atherosclerosis	1.05e-06	2.74e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.05e-06	2.73e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—atherosclerosis	1.05e-06	2.73e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOA1—atherosclerosis	1.05e-06	2.73e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—atherosclerosis	1.03e-06	2.68e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD36—atherosclerosis	1.03e-06	2.67e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.03e-06	2.67e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—atherosclerosis	1.02e-06	2.66e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—atherosclerosis	1.02e-06	2.64e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—INS—atherosclerosis	9.97e-07	2.59e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—atherosclerosis	9.93e-07	2.57e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NOS3—atherosclerosis	9.8e-07	2.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—atherosclerosis	9.77e-07	2.53e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—NOS3—atherosclerosis	9.74e-07	2.53e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—INS—atherosclerosis	9.74e-07	2.52e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—atherosclerosis	9.61e-07	2.49e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARA—atherosclerosis	9.59e-07	2.49e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AGT—atherosclerosis	9.28e-07	2.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—atherosclerosis	9.27e-07	2.41e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.16e-07	2.38e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—atherosclerosis	9.14e-07	2.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOE—atherosclerosis	9.1e-07	2.36e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—INS—atherosclerosis	9.09e-07	2.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CAV1—atherosclerosis	9.01e-07	2.34e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOA1—atherosclerosis	8.99e-07	2.33e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—atherosclerosis	8.96e-07	2.32e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—atherosclerosis	8.93e-07	2.31e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—atherosclerosis	8.91e-07	2.31e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOB—atherosclerosis	8.77e-07	2.28e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NOS3—atherosclerosis	8.75e-07	2.27e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—atherosclerosis	8.56e-07	2.22e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NOS3—atherosclerosis	8.54e-07	2.21e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.53e-07	2.21e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LPL—atherosclerosis	8.38e-07	2.17e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—atherosclerosis	8.34e-07	2.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—atherosclerosis	8.21e-07	2.13e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPX1—atherosclerosis	8.17e-07	2.12e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—atherosclerosis	8e-07	2.07e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NOS3—atherosclerosis	7.98e-07	2.07e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD36—atherosclerosis	7.96e-07	2.06e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—atherosclerosis	7.92e-07	2.06e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—atherosclerosis	7.84e-07	2.03e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—atherosclerosis	7.81e-07	2.03e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—INS—atherosclerosis	7.77e-07	2.02e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.54e-07	1.96e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARA—atherosclerosis	7.4e-07	1.92e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—atherosclerosis	7.29e-07	1.89e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AGT—atherosclerosis	7.17e-07	1.86e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—atherosclerosis	7.13e-07	1.85e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOE—atherosclerosis	7.02e-07	1.82e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CAV1—atherosclerosis	6.96e-07	1.8e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOA1—atherosclerosis	6.94e-07	1.8e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NOS3—atherosclerosis	6.82e-07	1.77e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.34e-07	1.64e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—atherosclerosis	6.23e-07	1.62e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—atherosclerosis	6.12e-07	1.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—INS—atherosclerosis	6e-07	1.56e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—atherosclerosis	5.5e-07	1.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NOS3—atherosclerosis	5.26e-07	1.36e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—atherosclerosis	5.2e-07	1.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.81e-07	1.25e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—atherosclerosis	4.5e-07	1.17e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—atherosclerosis	4.48e-07	1.16e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—atherosclerosis	4.02e-07	1.04e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—atherosclerosis	3.92e-07	1.02e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—atherosclerosis	3.67e-07	9.51e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—atherosclerosis	3.13e-07	8.13e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—atherosclerosis	2.42e-07	6.27e-06	CbGpPWpGaD
